Sponsor Pipeline

Sheng Tai Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07639983 Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for… Muscle-Invasive Bladder Cancer (MIBC) Not Yet Recruiting
Disease Areas
Bladder Cancer (1)
Get alerts when Sheng Tai's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free